National Oxygen Ltd Q1 Results: Net loss widens to ₹2.01 crore on plant shutdown

2 min read     Updated on 12 Aug 2026, 05:54 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

National Oxygen Ltd posted a Q1FY26 net loss of ₹200.64 lakh, up from ₹187.03 lakh YoY, as revenue fell nearly 60% to ₹304.50 lakh. The results reflect the impact of shutting down its Pondicherry liquid plant due to high operating costs and competition, leaving Industrial Gases as its sole business segment.

powered bylight_fuzz_icon
48083080

*this image is generated using AI for illustrative purposes only.

National Oxygen Limited reported a net loss of ₹200.64 lakh for the quarter ended June 30, 2026 (Q1FY26), widening from a loss of ₹187.03 lakh in the same period of FY25. The deterioration in profitability was primarily driven by a sharp decline in revenue and structural changes in operations, specifically the shutdown of its liquid plant in Pondicherry. This operational shift has significantly impacted the company’s cost structure and top-line growth prospects for the fiscal year.

The Board of Directors approved the unaudited standalone financial results on August 12, 2026, pursuant to Regulation 30 and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and accompanied by a limited review report issued by the statutory auditors, PSDY & Associates. The financial statements were prepared in accordance with Indian Accounting Standard 34 (Ind AS 34) "Interim Financial Reporting".

Revenue from operations contracted sharply to ₹304.50 lakh in Q1FY26, down from ₹758.45 lakh in Q1FY25, representing a year-on-year decline of approximately 59.85%. Total income stood at ₹328.81 lakh, compared to ₹763.90 lakh in the corresponding previous period. Other income also saw a modest increase to ₹24.31 lakh from ₹5.45 lakh a year ago.

Metric Q1FY26 (₹ Lakh) Q1FY25 (₹ Lakh) Change
Revenue from Operations 304.50 758.45 -59.85%
Total Income 328.81 763.90 -56.96%
Total Expenses 529.45 950.92 -44.32%
Net Loss (200.64) (187.03) Widened
Earnings Per Share (3.98) (3.71) Deteriorated

Total expenses amounted to ₹529.45 lakh, down from ₹950.92 lakh in Q1FY25. However, the reduction in expenses did not offset the drop in revenue, leading to a pre-tax loss of ₹200.64 lakh. Key expense components included employee benefit expenses of ₹56.73 lakh, financial costs of ₹46.03 lakh, and depreciation & amortisation of ₹54.56 lakh. Power and fuel costs remained significant at ₹91.37 lakh, while other expenditure stood at ₹150.74 lakh.

Operational Impact

The financial performance was heavily influenced by strategic operational decisions. Note 5 of the financial results states that the company stopped liquid plant operations at its Pondicherry unit effective April 6, 2026. This decision was taken due to severe competition and a steep hike in various operating expenses, including power costs, maintenance, and transportation. Consequently, the company now operates only one reportable primary business segment: Industrial Gases.

What the Numbers Show

The divergence between the revenue decline (-59.85%) and the expense reduction (-44.32%) highlights the fixed-cost burden remaining after the Pondicherry plant shutdown. While variable costs associated with the liquid plant have ceased, significant overheads such as employee benefits, financial costs, and depreciation persist. The widening net loss indicates that the cost savings from the shutdown have not yet fully materialized into improved margins, or that the revenue lost from the unit outweighs the saved operational costs in the short term. Investors should monitor whether the streamlined operations lead to margin stabilization in subsequent quarters.

Historical Stock Returns for National Oxygen

1 Day5 Days1 Month6 Months1 Year5 Years
+0.20%-3.25%-4.95%-29.79%-55.60%+16.55%

How will National Oxygen Limited plan to offset the 60% revenue drop from the Pondicherry plant shutdown to stabilize its top-line growth in FY26?

What specific measures is management implementing to reduce the remaining fixed costs, such as employee benefits and depreciation, to improve margin efficiency?

Will the company pursue asset monetization or divestment of non-core assets to alleviate its financial cost burden and improve cash flow?

National Oxygen seeks approval for asset sales, new MOA at Aug 28 AGM

2 min read     Updated on 06 Aug 2026, 03:43 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

National Oxygen Limited turns profitable in FY26 due to asset sales and seeks shareholder approval for further disposals and governance updates at its upcoming AGM.

powered bylight_fuzz_icon
46966018

*this image is generated using AI for illustrative purposes only.

National Oxygen Limited will hold its 51st Annual General Meeting (AGM) on Friday, August 28, 2026, via video conference to seek shareholder approval for the sale of plant and machinery at its SIPCOT Perundurai and Pondicherry units. The meeting also aims to adopt new Memorandum of Association (MOA) and Articles of Association (AOA) aligned with the Companies Act, 2013, and reappoint Managing Director Rajesh Kumar Saraf. These strategic moves follow a ₹183.66 lakh net profit in FY26, driven by an exceptional gain of ₹812.26 lakh from asset sales, reversing a ₹700.22 lakh loss in FY25.

The AGM is scheduled for 11:30 A.M. (IST) and does not require physical presence. Shareholders must hold shares as of the cut-off date, Friday, August 21, 2026, to be eligible for e-voting. The e-voting window opens on Tuesday, August 25, 2026, at 09:00 A.M. and closes on Thursday, August 27, 2026, at 05:00 P.M. To ensure eligibility, the Register of Members and Share Transfer Books will remain closed from Saturday, August 22, 2026, through Friday, August 28, 2026. Central Depository Services Limited (CDSL) serves as the e-voting intermediary, while M/S Lakshmmi Subramanian & Associates acts as the scrutinizer.

Asset Disposal and Governance Updates

The Board seeks special resolutions to sell or dispose of assets at two key locations where production has been permanently discontinued. At the SIPCOT Perundurai unit, production ceased effective May 12, 2025. At the Pondicherry Liquid Production Unit, production stopped effective April 7, 2026. Proceeds from these sales are designated for repaying secured and unsecured bank borrowings and meeting working capital requirements. No purchaser has been identified yet, and the sale consideration remains undetermined.

Agenda Item Description Regulatory Basis
Asset Sale (SIPCOT) Disposal of plant, machinery, lease land, and building Section 180(1)(a), Companies Act, 2013; Reg 37A, SEBI LODR
Asset Sale (Pondicherry) Disposal of plant and machinery in Liquid Unit Section 180(1)(a), Companies Act, 2013; Reg 37A, SEBI LODR
MOA Adoption Replace existing MOA with new version per Companies Act, 2013 Section 4 & 13, Companies Act, 2013
AOA Adoption Replace existing AOA with new version per Table F, Schedule I Section 14, Companies Act, 2013

Additionally, Rajesh Kumar Saraf, Managing Director, retires by rotation and offers himself for re-appointment. He holds 17,66,037 shares and drew remuneration of ₹54,00,000 in FY26. The Board noted the demise of Gajanand Saraf, Whole-Time Director, who passed away on April 6, 2026. Statutory auditor PSDY & Associates issued an unqualified report on the financial statements.

What the Numbers Show

The transition to profitability in FY26 is structural rather than operational, entirely dependent on the one-time exceptional gain of ₹812.26 lakh from asset sales. Excluding this benefit, the company would have recorded a pre-tax loss, highlighting that core business profitability remains under pressure from reduced capacity. While the reduction in interest expenses indicates improved debt management, the reliance on asset monetization underscores the urgency for sustainable operational improvements in the remaining units to support long-term viability.

Historical Stock Returns for National Oxygen

1 Day5 Days1 Month6 Months1 Year5 Years
+0.20%-3.25%-4.95%-29.79%-55.60%+16.55%

How will the proceeds from the SIPCOT and Pondicherry asset sales specifically impact National Oxygen's debt-to-equity ratio and interest coverage in the upcoming fiscal year?

What is the management's strategic roadmap for revitalizing core operational profitability at the remaining active units after the one-time asset gains are excluded?

How might the reappointment of MD Rajesh Kumar Saraf and the recent loss of Whole-Time Director Gajanand Saraf influence the company's governance stability and executive decision-making?

More News on National Oxygen

1 Year Returns:-55.60%